Please login to the form below
LifeArc
This page shows the latest LifeArc news and features for those working in and with pharma, biotech and healthcare.
LifeArc creates £10m COVID-19 research fund
Medical research charity joins efforts against coronavirus. UK-based medical research charity LifeArc has launched a £10m fund in support of research efforts against the novel coronavirus, which causes the disease ... There is a clear, urgent need now
Latest news
-
LifeArc takes $30m equity stake in Kymab, gains access to antibody tech
LifeArc is to make an initial $10m equity investment in Kymab, with a further $20m to follow. ... Kymab will also receive a percentage of revenues from any products discovered and commercialised by LifeArc using its technologies.
-
Research charity LifeArc cashes $1.2bn royalty from Keytruda
LifeArc is now making the most of its significant contribution to the drug’s development. ... For LifeArc, the money opens up new possibilities in the translational medicine field.
-
Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers
Will also advance proteomics research. The UK’s Medicines Discovery Catapult has teamed up with LifeArc in a bid to develop novel biomarkers and optimise the medical charity's drug development. ... LifeArc will fund a select number of full-time
-
Pfizer spins out SpringWorks Therapeutics biotech
funding from the drugmaker plus venture capitalists Bain Capital and Orbimed and medical charity LifeArc.
LifeArc takes $30m equity stake in Kymab, gains access to antibody tech
Research charity LifeArc cashes $1.2bn royalty from Keytruda
Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers
Pfizer spins out SpringWorks Therapeutics biotech
More from news
Approximately 3 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
25 Women Leaders in UK Healthcare
Today Melanie is chief executive of the medical research charity LifeArc, which she joined late last year, and which is about to transformed by a $1.29bn royalty deal based on ... I left the industry to be able to facilitate that, and that’s what
25 Women Leaders in UK Healthcare
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
The RARE Youth Revolution has begun
LifeArc. Sobi. “We are a proud supporter of RARE Youth Revolution and we are absolutely thrilled to have them as part of the Breaking Down Barriers project!
The RARE Youth Revolution has begun
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Associate Account Director
-
Competitive Salary
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
-
Account Management
-
Competitive Salary Offered
-
Account Manager
-
Competitive Salary
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Competitive Salary
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
-
Medical Editor
-
Competitive Salary
-
Senior Account Executive
-
Competitive Salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Publications Director
-
Competitive Salary
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Merck & Co reveals plans for women’s health spinoff Organon
- Positive results for GSK/CureVac’s COVID-19 vaccine
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- Biogen and Capsigen to collaborate on gene therapies
- CanSinoBIO considers booster jab for COVID-19 vaccine
- Research Partnership’s MedTech Division appoints two Directors
- VMLY&Rx launches new payer agency in the US
- Biogen and Envisagenics to advance RNA splicing research for CNS diseases
- Positive results for GSK/CureVac’s COVID-19 vaccine
- New trial data for Keytruda in triple-negative breast cancer
- NICE recommends Keytruda for colorectal cancer patients with rare mutations
- Merck & Co reveals plans for women’s health spinoff Organon
- UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D
- Why female mentorship is so powerful in pharma
- Positive results for GSK/CureVac’s COVID-19 vaccine
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Can protein degraders unlock ‘undruggable’ drug targets?
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- How innovating study sites can improve patient recruitment efficiency
- There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
- 6 reasons patients drop out of clinical trials and 6 ways to fix it
- If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
